https://openbell.ai/ 2026-10-07T15:53:14.119Z hourly 1.0 https://openbell.ai/support 2026-10-07T15:53:14.119Z monthly 0.7 https://openbell.ai/privacy 2026-10-07T15:53:14.119Z monthly 0.5 https://openbell.ai/terms 2026-10-07T15:53:14.119Z monthly 0.5 https://openbell.ai/feed.json 2026-10-07T15:53:14.119Z hourly 0.8 https://openbell.ai/news/OPCH:1791388363544 2026-10-07T15:52:43.544Z daily 0.9 https://cdn.brandfetch.io/OPCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday Barrington Research analyst Michael Petusky downgraded Option Care Health Inc (NASDAQ: OPCH) from Outperform to Market Perform, with shares closing at $31.00 on Tuesday. This downgrade is part of a broader trend, as several analysts adjusted their ratings on various companies, including PJT Partners Inc and Caribou Biosciences Inc. The market is reacting to these changes, reflecting analysts' revised outlooks on these stocks. https://openbell.ai/news/BMNR:1791388319606 2026-10-07T15:51:59.606Z daily 0.9 https://cdn.brandfetch.io/BMNR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tom Lee Says Bitmine Will 'Stop' Buying ETH—BMNR Falls 6% Bitmine (NYSE: BMNR) experienced a 6% decline in stock price after Chairman Tom Lee announced the company will cease purchasing Ethereum (ETH) once it reaches a 5% supply target, needing approximately 100,000 more ETH to achieve this. Currently, Bitmine holds 6,016,414 ETH, about 4.9% of the circulating supply, and reported $643 million in cash and marketable securities. The company's recent buying spree has resulted in $4.5 billion in unrealized losses, raising concerns about the impact on ETH demand as multiple companies vie for limited supply. https://openbell.ai/news/ACEL:1791388040806 2026-10-07T15:47:20.806Z daily 0.9 https://cdn.brandfetch.io/ACEL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Maintains Outperform on Accel Entertainment, Raises Price Target to $17 Macquarie analyst Chad Beynon has maintained an 'Outperform' rating on Accel Entertainment (NYSE: ACEL) and raised the price target from $16 to $17. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/STDN:1791387979840 2026-10-07T15:46:19.840Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/3d-Rendering-Smr-Or-Small-Modular-Nuclea.jpg?width=250&height=187 Analyst Says Standard Nuclear Is the Only Company Shipping a Key Advanced-Reactor Fuel Needham analyst Sean Milligan has initiated coverage on Standard Nuclear (NYSE: STDN) with a Buy rating and a price target of $18. The company is the only commercial supplier of TRISO nuclear fuel, which positions it advantageously as demand for advanced reactors increases. Revenue is projected to reach approximately $329 million in 2028, $1.08 billion in 2030, and peak at $1.767 billion in 2033. Currently, STDN shares are trading at $14.11, down 7.11% at the time of publication. https://openbell.ai/news/WFC:1791387773926 2026-10-07T15:42:53.926Z daily 0.9 https://cdn.brandfetch.io/WFC/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Wells Fargo Faces Regulator Probe Over Efforts to Boost Black Homeownership' - WSJ Exclusive Wells Fargo is currently under investigation by regulators concerning its initiatives aimed at increasing Black homeownership. The probe is focused on the bank's practices and efforts in this area, which may have implications for its compliance and operational strategies. The outcome of this investigation could potentially impact Wells Fargo's reputation and financial performance. https://openbell.ai/news/ZS:1791387663219 2026-10-07T15:41:03.219Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Zscaler, Raises Price Target to $225 Barclays analyst Saket Kalia has maintained an Overweight rating on Zscaler (NASDAQ: ZS) and raised the price target from $220 to $225. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/WST:1791387526944 2026-10-07T15:38:46.944Z daily 0.9 https://cdn.brandfetch.io/WST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $440 Barclays analyst Luke Sergott has maintained an Overweight rating on West Pharmaceutical Services (NYSE: WST) and raised the price target from $400 to $440. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/ONC:1791387497366 2026-10-07T15:38:17.366Z daily 0.9 https://cdn.brandfetch.io/ONC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on BeOne Medicines, Raises Price Target to $420 Truist Securities analyst Gregory Renza has maintained a Buy rating on BeOne Medicines (NASDAQ: ONC) and raised the price target from $418 to $420. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/WAT:1791387446325 2026-10-07T15:37:26.325Z daily 0.9 https://cdn.brandfetch.io/WAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Waters, Raises Price Target to $500 Barclays analyst Luke Sergott has maintained an Overweight rating on Waters (NYSE: WAT) and increased the price target from $460 to $500. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/VOYA:1791387397676 2026-10-07T15:36:37.676Z daily 0.9 https://cdn.brandfetch.io/VOYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Voya Financial, Raises Price Target to $109 Barclays analyst Alex Scott has maintained an Overweight rating on Voya Financial (NYSE: VOYA) and increased the price target from $105 to $109. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/GOOG:1791387301216 2026-10-07T15:35:01.216Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Jakarta---July-07-2Unity-Software-Inc.jpg?width=250&height=187 Google Taps Unity to Bring AI Game Creation to the Masses Unity Software Inc. has announced a partnership with Alphabet Inc.'s Google to launch an integrated gaming platform later this year, combining Google's AI technology with Unity's game development tools. The new platform, starting with the Playground, allows users to create games using text prompts without coding, with plans to introduce Unity Spark for more advanced features. This initiative is seen as a competitive challenge to Roblox, which is also developing AI tools for game creation. https://openbell.ai/news/TWST:1791387183380 2026-10-07T15:33:03.380Z daily 0.9 https://cdn.brandfetch.io/TWST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $215 Barclays analyst Luke Sergott has maintained an Overweight rating on Twist Bioscience (NASDAQ: TWST) and raised the price target significantly from $112 to $215. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/AMD:1791387106096 2026-10-07T15:31:46.096Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Amd-Chairman-And-Ceo-Lisa-Su-Delivers-Th.jpg?width=250&height=187 Surging Over 200% in 2026: AMD Balances Near-Term Yield Pressures with Long-Term AI Growth Advanced Micro Devices Inc. (AMD) has seen its stock surge over 200% in 2026, reaching a market value of over $1 trillion in September. Despite facing near-term pressures from rising Treasury yields and energy costs, AMD's long-term growth is supported by increasing demand for chips and data center infrastructure, particularly in AI applications. The company plans to ramp up chip supply in 2027 and is collaborating with major suppliers to meet anticipated demand. Analysts have raised their price targets for AMD, with Citigroup forecasting $800 and Mizuho projecting $705. https://openbell.ai/news/TMO:1791387052713 2026-10-07T15:30:52.713Z daily 0.9 https://cdn.brandfetch.io/TMO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750 Barclays analyst Luke Sergott has maintained an Overweight rating on Thermo Fisher Scientific (NYSE: TMO) and increased the price target from $650 to $750. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/USO:1791386920863 2026-10-07T15:28:40.863Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Attacks on tankers in Hormuz hit highest of any week since start of Iran war, sources say'- Reuters Recent reports indicate that attacks on tankers in the Hormuz Strait have reached the highest frequency in any week since the onset of the Iran war. This escalation in maritime violence could have significant implications for global oil supply and prices, particularly affecting companies and funds like USO that are tied to oil markets. https://openbell.ai/news/SKYD:1791386785128 2026-10-07T15:26:25.128Z daily 0.9 https://cdn.brandfetch.io/SKYD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Underweight on Skydance, Lowers Price Target to $7 Barclays analyst Kannan Venkateshwar has maintained an Underweight rating on Skydance (NYSE: SKYD) and has lowered the price target from $8 to $7. This adjustment reflects the analyst's outlook on the company's performance. https://openbell.ai/news/MRVL:1791386635248 2026-10-07T15:23:55.248Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wolfe Research Maintains Outperform on Marvell Technology, Raises Price Target to $375 Wolfe Research analyst Chris Caso has reiterated an Outperform rating on Marvell Technology (NASDAQ: MRVL) and increased the price target from $280 to $375. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/IREN:1791386597805 2026-10-07T15:23:17.805Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching IREN; Shares Moving Lower; Traders Circulate X Post Saying "IREN continues to come up in our conversations with neocloud customers, and usually for the wrong reasons. In Prince George and Mackenzie in Northern BC, Canada, we’ve heard the stories: multi-day power outages, network upgrades, storage failures, air quality controls leading to link flaps, XIDs everywhere. The #1 worst site in the industry, according to users..." IREN shares are experiencing a decline as traders discuss negative feedback from neocloud customers regarding the company's performance. Reports from Prince George and Mackenzie in Northern BC highlight issues such as multi-day power outages, network upgrades, and storage failures, with users labeling it the 'worst site in the industry.' https://openbell.ai/news/HOOD:1791386552901 2026-10-07T15:22:32.901Z daily 0.9 https://cdn.brandfetch.io/HOOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Robinhood Markets, Raises Price Target to $132 Barclays analyst Benjamin Budish has maintained an Overweight rating on Robinhood Markets (NASDAQ: HOOD) and increased the price target from $105 to $132. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/RVTY:1791386493330 2026-10-07T15:21:33.330Z daily 0.9 https://cdn.brandfetch.io/RVTY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $160 Barclays analyst Luke Sergott has maintained an Equal-Weight rating on Revvity (NYSE: RVTY) while raising the price target from $115 to $160. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/COIN:1791386486446 2026-10-07T15:21:26.446Z daily 0.9 https://cdn.brandfetch.io/COIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of crypto-linked companies are trading lower amid a drop in Bitcoin after rising yields, a stronger dollar and ongoing conflict in the Middle East cool risk appetite. openbell Financial News https://openbell.ai/news/ZS:1791386447187 2026-10-07T15:20:47.187Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stephens & Co. Maintains Overweight on Zscaler, Raises Price Target to $265 Stephens & Co. analyst Todd Weller has maintained an Overweight rating on Zscaler (NASDAQ: ZS) and raised the price target from $225 to $265. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/RGEN:1791386440172 2026-10-07T15:20:40.172Z daily 0.9 https://cdn.brandfetch.io/RGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Repligen, Raises Price Target to $225 Barclays analyst Luke Sergott has maintained an Overweight rating on Repligen (NASDAQ:RGEN) and increased the price target from $175 to $225. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/RJF:1791386282095 2026-10-07T15:18:02.095Z daily 0.9 https://cdn.brandfetch.io/RJF/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Raymond James Finl, Raises Price Target to $197 Barclays analyst Benjamin Budish has maintained an Overweight rating on Raymond James Financial (NYSE: RJF) and increased the price target from $196 to $197. This adjustment reflects a positive outlook for the company in the financial markets. https://openbell.ai/news/DGX:1791386237329 2026-10-07T15:17:17.329Z daily 0.9 https://cdn.brandfetch.io/DGX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $260 Barclays analyst Luke Sergott has maintained an Overweight rating on Quest Diagnostics (NYSE: DGX) and increased the price target from $250 to $260. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/PGR:1791386145596 2026-10-07T15:15:45.596Z daily 0.9 https://cdn.brandfetch.io/PGR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Progressive, Raises Price Target to $247 Barclays analyst Alex Scott has reaffirmed an Overweight rating on Progressive (NYSE: PGR) and increased the price target from $246 to $247. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/META:1791386010785 2026-10-07T15:13:30.785Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Attorney General James Uthmeier Files for Temporary Injunction Against Meta Attorney General James Uthmeier has filed for a temporary injunction against Meta, aiming to address unspecified legal concerns. The filing could have implications for Meta's operations in the state, although specific details regarding the nature of the injunction or its potential impact on the company's stock price were not disclosed. https://openbell.ai/news/ATAT:1791385953030 2026-10-07T15:12:33.030Z daily 0.9 https://cdn.brandfetch.io/ATAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud HSBC Initiates Coverage On Atour Lifestyle Holdings with Buy Rating, Announces Price Target of $39.7 HSBC has initiated coverage on Atour Lifestyle Holdings (NASDAQ: ATAT) with a Buy rating. The investment bank has set a price target of $39.7 for the company's stock. https://openbell.ai/news/SPY:1791385899162 2026-10-07T15:11:39.162Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud NY Fed Says September Three-Year-Ahead Expected Inflation 3.3% Vs. August’s 3.2%; September One-year Ahead Expected Inflation Highest Since May 2023; September Five Year-Ahead Expected Inflation Unchanged At 3%; In September Households More Downbeat On Current And Future Financial Situation The New York Federal Reserve reported that the expected inflation rate for three years ahead increased to 3.3% in September, up from 3.2% in August. Additionally, the one-year ahead expected inflation reached its highest level since May 2023. The five-year ahead expected inflation remained unchanged at 3%. Households expressed a more pessimistic outlook on both their current and future financial situations. https://openbell.ai/news/PPL:1791385845471 2026-10-07T15:10:45.471Z daily 0.9 https://cdn.brandfetch.io/PPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Pembina Pipeline, Raises Price Target to C$70 Barclays analyst Theresa Chen has maintained an Overweight rating on Pembina Pipeline (TSX: PPL) and increased the price target from C$69 to C$70. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/DIS:1791385724762 2026-10-07T15:08:44.762Z daily 0.9 https://cdn.brandfetch.io/DIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Disney+ Will Stream 2027 Super Bowl' - Variety Disney+ has secured the streaming rights for Super Bowl LXI, scheduled for 2027. This move is part of Disney's strategy to enhance its streaming service offerings and attract more subscribers. The announcement could potentially impact Disney's stock performance as it positions itself more prominently in the sports streaming market. https://openbell.ai/news/EGBN:1791385706480 2026-10-07T15:08:26.480Z daily 0.9 https://cdn.brandfetch.io/EGBN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hovde Group Initiates Coverage On Eagle Bancorp with Outperform Rating, Announces Price Target of $37 Hovde Group has initiated coverage on Eagle Bancorp (NASDAQ: EGBN) with an Outperform rating. The firm has set a price target of $37 for the company's stock. https://openbell.ai/news/NTRA:1791385706023 2026-10-07T15:08:26.023Z daily 0.9 https://cdn.brandfetch.io/NTRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Natera, Raises Price Target to $475 Barclays analyst Luke Sergott has maintained an Overweight rating on Natera (NASDAQ: NTRA) and raised the price target from $340 to $475. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/PPG:1791385540646 2026-10-07T15:05:40.646Z daily 0.9 https://cdn.brandfetch.io/PPG/w/400/h/400?c=1idopYfmtR7ZKg8QMud PPG Investing $70M To Expand Its Aerospace Transparencies Facility In Alabama PPG has announced a $70 million investment to expand its aerospace transparencies facility in Huntsville, Alabama. This investment is part of a series of multi-year projects aimed at increasing production capacity and supporting the growth of PPG's aerospace transparencies business. https://openbell.ai/news/MTD:1791385522842 2026-10-07T15:05:22.842Z daily 0.9 https://cdn.brandfetch.io/MTD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Mettler-Toledo Intl, Raises Price Target to $1700 Barclays analyst Luke Sergott has maintained an Overweight rating on Mettler-Toledo International (NYSE: MTD) and increased the price target from $1575 to $1700. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/MET:1791385466947 2026-10-07T15:04:26.947Z daily 0.9 https://cdn.brandfetch.io/MET/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on MetLife, Raises Price Target to $111 Barclays analyst Alex Scott has maintained an Overweight rating on MetLife (NYSE: MET) and increased the price target from $97 to $111. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/NEOG:1791385327058 2026-10-07T15:02:07.058Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Munich--Bavaria--Germany---March-31-2023.jpg?width=250&height=187 Neogen Shifts Focus to Scale Profitable Growth Neogen Corp. (NASDAQ: NEOG) reported first-quarter 2027 adjusted earnings of 8 cents per share, surpassing the consensus loss of 7 cents, with sales of $222.80 million, a 6.5% year-over-year increase, exceeding expectations. The Food Safety segment generated $163.2 million in revenue, while the Animal Safety segment contributed $59.6 million. Neogen raised its fiscal 2027 sales guidance to $885 million-$890 million, reflecting confidence in growth, despite a 2.93% decline in stock price to $11.61. https://openbell.ai/news/COIN:1791385239140 2026-10-07T15:00:39.140Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Eric-Trump-shutterstock-2519822947.jpg?width=250&height=187 Eric Trump Says Crypto Can 'Declare Victory' Over Banks: Is He Right? Eric Trump stated at the Token2049 conference in Singapore that cryptocurrency can 'declare victory' over traditional banks, noting that banks are now adopting digital assets after years of resistance. He highlighted that Bitcoin's recent price increase, trading above $80,000, is partly due to capital flowing back from AI stocks. Trump's comments also included a focus on tokenization as a means to democratize investment opportunities in assets typically reserved for wealthy individuals. This marks a shift from his previous warnings about banks becoming obsolete if they failed to embrace crypto. https://openbell.ai/news/MRX:1791385238149 2026-10-07T15:00:38.149Z daily 0.9 https://cdn.brandfetch.io/MRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Marex Group, Raises Price Target to $92 Barclays analyst Benjamin Budish has maintained an Overweight rating on Marex Group (NASDAQ: MRX) and increased the price target from $86 to $92. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/BMEA:1791385225028 2026-10-07T15:00:25.028Z daily 0.9 https://cdn.brandfetch.io/BMEA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brookline Capital Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $10 Brookline Capital has initiated coverage on Biomea Fusion (NASDAQ: BMEA) with a Buy rating. The firm has set a price target of $10 for the stock. https://openbell.ai/news/LPLA:1791385094956 2026-10-07T14:58:14.956Z daily 0.9 https://cdn.brandfetch.io/LPLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on LPL Finl Hldgs, Raises Price Target to $409 Barclays analyst Benjamin Budish has maintained an Overweight rating on LPL Financial Holdings (NASDAQ: LPLA) and raised the price target from $401 to $409. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/LNC:1791384996200 2026-10-07T14:56:36.200Z daily 0.9 https://cdn.brandfetch.io/LNC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Lincoln National, Raises Price Target to $48 Barclays analyst Alex Scott has maintained an Overweight rating on Lincoln National (NYSE: LNC) and increased the price target from $45 to $48. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/RPRX:1791384982204 2026-10-07T14:56:22.204Z daily 0.9 https://cdn.brandfetch.io/RPRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $67 Morgan Stanley analyst Terence Flynn has maintained an Overweight rating on Royalty Pharma (NASDAQ: RPRX) and raised the price target from $65 to $67. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/NXAT:1791384961644 2026-10-07T14:56:01.644Z daily 0.9 https://cdn.brandfetch.io/NXAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nexus Advanced Technologies Shares Halted On Circuit Breaker To The Upside, Stock Now Up 36.73% openbell Financial News https://openbell.ai/news/JXN:1791384942299 2026-10-07T14:55:42.299Z daily 0.9 https://cdn.brandfetch.io/JXN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Jackson Financial, Raises Price Target to $150 Barclays analyst Alex Scott has maintained an Overweight rating on Jackson Financial (NYSE: JXN) and increased the price target from $149 to $150. This adjustment reflects a positive outlook for the company in the financial market. https://openbell.ai/news/IQV:1791384844620 2026-10-07T14:54:04.620Z daily 0.9 https://cdn.brandfetch.io/IQV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on IQVIA Holdings, Raises Price Target to $300 Barclays analyst Luke Sergott has maintained an Overweight rating on IQVIA Holdings (NYSE: IQV) and raised the price target from $275 to $300. This adjustment reflects a positive outlook on the company's performance in the market. https://openbell.ai/news/ICE:1791384621483 2026-10-07T14:50:21.483Z daily 0.9 https://cdn.brandfetch.io/ICE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Intercontinental Exchange, Raises Price Target to $189 Barclays analyst Benjamin Budish has maintained an Overweight rating on Intercontinental Exchange (NYSE: ICE) and increased the price target from $182 to $189. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/IBKR:1791384532313 2026-10-07T14:48:52.313Z daily 0.9 https://cdn.brandfetch.io/IBKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Interactive Brokers Group, Raises Price Target to $115 Barclays analyst Benjamin Budish has maintained an Overweight rating on Interactive Brokers Group (NASDAQ: IBKR) and increased the price target from $114 to $115. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/LPCN:1791384257498 2026-10-07T14:44:17.498Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Healthcare-Costs-Fuel-BNPL-Growth.jpg?width=250&height=187 Canadian Approval Of Lipocine Drug Marks Progress for Oral Testosterone Options In Canada Health Canada has approved Lipocine Inc.'s TLANDO (testosterone undecanoate) capsules for use as testosterone replacement therapy in adult males with testosterone deficiency. Verity Pharmaceuticals, which holds exclusive commercial rights for TLANDO in North America, plans to launch the product in Canada by the end of 2026. The Canadian TRT market presents a significant opportunity, with over 700,000 prescriptions written annually, and Lipocine aims to capture market share with TLANDO's oral formulation, which offers convenience over traditional injection and gel methods. Following the approval, Lipocine's stock rose 15.72% to $2.43. https://openbell.ai/news/FMS:1791384129149 2026-10-07T14:42:09.149Z daily 0.9 https://cdn.brandfetch.io/FMS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fresenius Medical Care Shares Halted, News Pending openbell Financial News